Your session is about to expire
← Back to Search
Imaging
Whole-body FDG PET-CT alone for Breast Cancer (PET ABC Trial)
N/A
Waitlist Available
Led By Ian Dayes, MD
Research Sponsored by Ontario Clinical Oncology Group (OCOG)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of randomization to date of event, assessed up to 5 years
Awards & highlights
PET ABC Trial Summary
This trial is comparing two ways of staging cancer to see which is better.
Eligible Conditions
- Stage III Breast Cancer
- Breast Cancer
PET ABC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from date of randomization to date of event, assessed up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of randomization to date of event, assessed up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of patients upstaged to Stage IV disease
Secondary outcome measures
Disease Free Survival
Incremental economic analysis comparing the costs and outcomes of the treatment arms
Number of additional tests, such as imaging and biopsy, resulting from findings of study imaging
+3 morePET ABC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Whole-body FDG PET-CT aloneExperimental Treatment1 Intervention
Group II: Conventional breast cancer stagingActive Control1 Intervention
Conventional breast cancer staging consisting of a bone scan and CT imaging with contrast of the chest / abdomen & pelvis
Find a Location
Who is running the clinical trial?
Ontario Clinical Oncology Group (OCOG)Lead Sponsor
63 Previous Clinical Trials
41,556 Total Patients Enrolled
16 Trials studying Breast Cancer
9,118 Patients Enrolled for Breast Cancer
Cancer Care OntarioOTHER
16 Previous Clinical Trials
91,664 Total Patients Enrolled
Ian Dayes, MDPrincipal InvestigatorJuravinski Hospital and Cancer Centre
1 Previous Clinical Trials
103 Total Patients Enrolled
1 Trials studying Breast Cancer
103 Patients Enrolled for Breast Cancer
Share this study with friends
Copy Link
Messenger